Clinical Study

Choroid and Retinal Nerve Fiber Layer Thickness in Patients with Chronic Obstructive Pulmonary Disease Exacerbation

Table 1

Clinical and demographic characteristics of the COPD and control groups.

Group A ()Group B ()Control ()

Age (y)64.1 ± 7.364.4 ± 8.665.8 ± 7.10.073A
FEV1/FVC63.9 ± 14.871.1 ± 13.190.2 ± 4.20.092m
FEV11.6 ± 0.72.0 ± 0.82.2 ± 0.50.054m
O289.3 ± 8.594.2 ± 4.498 ± 0.90.009m

Group A: COPD at the exacerbation period; Group B: COPD at the stable period; AANOVA; mMann–Whitney U test; FEV1: forced expiratory volume; FVC: forced vital capacity; O2: oxygen saturation; y: year.